University of North Carolina at Chapel Hill - Comprehensive Sickle Cell Program is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
University of North Carolina at Chapel Hill - Comprehensive Sickle Cell Program has participated in 1 clinical trials.
Therapeutic areas: Sickle Cell Disease, Sickle Cell Anemia, Sickle Cell Disorders.
Sponsors: HemaQuest Pharmaceuticals Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of North Carolina at Chapel Hill - Comprehensive Sickle Cell Program has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of North Carolina at Chapel Hill - Comprehensive Sickle Cell Program has 1 clinical trials on record. Their work covers Sickle Cell Disease, Sickle Cell Anemia, Sickle Cell Disorders.
University of North Carolina at Chapel Hill - Comprehensive Sickle Cell Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.